E.g., 10/25/2020
E.g., 10/25/2020

bioMérieux to Break Ground on Eco-Friendly Facility on the Hazelwood Campus

06 October, 2008

October 6 groundbreaking ceremony expands company’s presence in the U.S.

bioMérieux to Develop New Highly-Specific, Non-Invasive Test for Prostate Cancer, Reducing Unnecessary Biopsies

25 September, 2008

Prostate cancer is the most prevalent cancer in the United States and the 4th most common worldwide. The combination of a test for a new prostate cancer biomarker, Annexin 3, with the standard screening methods could potentially reduce the number of biopsies conducted by up to 75%, when compared with current screening methods alone.

bioMérieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx

11 September, 2008

bioMérieux, a world leader in the field of in vitro diagnostics has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, based in San Diego, California (USA). AviaraDx’s diagnostic tests, based on their proprietary technologies, are used in the molecular classification of cancers and to assist oncologists in making critical therapeutic decisions. The company has built a molecular R&D lab and a small sales & marketing team, as well as a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified service lab.

First-Half 2008 Financial Report

08 September, 2008

bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its interim financial report for the first six months of 2008.

Steve Harbin's Appointment

01 September, 2008

A world leader in the field of in vitro diagnostics, bioMérieux has appointed Steve Harbin as Corporate Vice President, Quality Management Systems, Health, Safety and Environment and Internal Control, effective July 15, 2008.

bioMérieux Delivers New Clean Room Range for Sterility Testing

01 September, 2008

pharma_media1_thumb15.jpg Show in media library:  bioMérieux, a world leader in in vitro diagnostics, launches sterility media bottles in a new format, the Clean Room Range, for ultimate quality and ease of use in final product testing of sterile pharmaceutical compounds.

bioMérieux to Reveal the Latest Food Safety Technology at the International Association of Food Protection Annual Meeting

30 July, 2008

Seventh Annual Symposium to cover food-borne outbreaks including Salmonella and E. coli O157:H7.

bioMérieux Unveils Groundbreaking E. coli O157:H7 Detection Technology at Food Safety Meeting (IAFP*)

29 July, 2008

VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Level

U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis

24 July, 2008

Survey shows hospital physicians, pulmonary and critical care clinicians, and researchers also concerned about overuse of antibiotics.

Pioneering Diagnostics